Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase 2 2

Status

Unknown 1Completed 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Sarcoma 9Rhabdomyosarcoma 5Wilms Tumor 2Ovarian Neoplasms 2Melanoma 2Malignant mesenchymal tumor 2Gestational Trophoblastic Disease 2Fibrosarcoma 2Testicular Neoplasms 1Teratoma, Ovarian 1Sarcoma, Alveolar Soft Part 1Rhabdoid Tumor 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Germ Cell and Embryonal 1Liposarcoma 1Kidney Neoplasms 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Desmoplastic Small Round Cell Tumor 1Dermatofibrosarcoma 1Chondrosarcoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1

Interventions

X-Rays 7Phantoms, Imaging 7Magnetic Resonance Spectroscopy 7Specimen Handling 6Vincristine 5Radiotherapy 5Nuclear Medicine Department, Hospital 5Doxorubicin 5Biopsy 5Etoposide 4Cyclophosphamide 4Carboplatin 4Topotecan 3Filgrastim 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2cabozantinib 2Vemurafenib 2Surgical Procedures, Operative 2Radiation 2Methylprednisolone 2LY3023414 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Wilms Tumor × Dactinomycin × Clear all
NCT00335556 2017-07-21

Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors

Children's Oncology Group

Phase 2 Completed
291 enrolled 18 charts
Genitourinary

Carcinoma, Renal Cell, Wilms Tumor

NCT00025103 2013-08-02

Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney

National Cancer Institute (NCI)

Phase 2 Unknown
75 enrolled
Genitourinary

Kidney Neoplasms, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡